SUBSCRIBE
SUBSCRIBE

Dermatology

Loss of one drug name. Ban on a drug or its shortage. Exclusion from the list of free drugs available under the medical social program.
Rare diseases
InflaRx Axes Rare Skin Disease Study on Disappointing Late-Stage Data
InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.
May 28, 2025
 · 
2 min read
 · 
Tristan Manalac
Load More
PRESS RELEASES
Press Releases
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
May 14, 2026
 · 
7 min read
Press Releases
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
May 14, 2026
 · 
18 min read
Press Releases
Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis
May 13, 2026
 · 
3 min read
Press Releases
Crescita Reports First Quarter 2026 Results
May 11, 2026
 · 
17 min read
Press Releases
TRexBio to Present Late-Breaking Data at the Society for Investigative Dermatology (SID) Annual Meeting Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis
May 8, 2026
 · 
3 min read
Press Releases
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis
May 7, 2026
 · 
8 min read
Press Releases
Orvida Pharma to Present Functional Endpoint Development Data in Rare Palmoplantar Skin Disorders at the 83rd Annual Meeting of the Society for Investigative Dermatology and the 2026 Epidermal Differentiation Disorders Symposium
May 5, 2026
 · 
3 min read
Press Releases
LEO Pharma Delivers 9% Revenue Growth at CER in Q1 2026 and Strengthens Innovation Pipeline
May 5, 2026
 · 
3 min read
Press Releases
Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting
May 4, 2026
 · 
2 min read
Press Releases
Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall
May 4, 2026
 · 
5 min read
Press Releases
LEO Pharma Bolsters Rare Skin Disease Focus Through Acquisition of Replay Gene Therapy Platform
April 30, 2026
 · 
4 min read
Press Releases
FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026
April 30, 2026
 · 
1 min read
Press Releases
Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis
April 30, 2026
 · 
4 min read
Press Releases
Veradermics Announces Pricing of Upsized Public Offering and Private Placement
April 30, 2026
 · 
5 min read
Press Releases
TRexBio Doses First Patient with Moderate-to-Severe Atopic Dermatitis in Phase 1b Clinical Trial of TRB-061, a TNFR2 Agonist
April 29, 2026
 · 
4 min read
Press Releases
Dermalogica Expands Professional Portfolio with Launch of PRO Pen Microneedling System
April 28, 2026
 · 
5 min read
Press Releases
Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months
April 27, 2026
 · 
10 min read
Press Releases
LEO Pharma expands its psoriasis portfolio in China with NMPA approval of Enstilar®
April 17, 2026
 · 
6 min read
Press Releases
Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform
April 16, 2026
 · 
7 min read
Press Releases
LEO Pharma Announces FDA Acceptance of Supplemental NDA for ANZUPGO® (delgocitinib) Cream for the Treatment of Chronic Hand Eczema in Children Aged 12-17
April 15, 2026
 · 
13 min read
Load More